Free Trial

HM Payson & Co. Sells 3,277 Shares of Procter & Gamble Company (The) (NYSE:PG)

Procter & Gamble logo with Consumer Staples background

HM Payson & Co. trimmed its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 1.4% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 226,821 shares of the company's stock after selling 3,277 shares during the period. HM Payson & Co.'s holdings in Procter & Gamble were worth $38,655,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of PG. Navigoe LLC bought a new stake in shares of Procter & Gamble in the fourth quarter valued at about $31,000. Capital A Wealth Management LLC acquired a new stake in shares of Procter & Gamble in the fourth quarter valued at about $31,000. Hoey Investments Inc. increased its position in shares of Procter & Gamble by 321.7% in the fourth quarter. Hoey Investments Inc. now owns 194 shares of the company's stock valued at $33,000 after acquiring an additional 148 shares during the last quarter. LFA Lugano Financial Advisors SA acquired a new stake in shares of Procter & Gamble in the fourth quarter valued at about $34,000. Finally, 10Elms LLP acquired a new stake in shares of Procter & Gamble in the fourth quarter valued at about $34,000. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock traded down $0.48 on Friday, hitting $160.72. The stock had a trading volume of 6,999,589 shares, compared to its average volume of 7,494,586. Procter & Gamble Company has a twelve month low of $156.58 and a twelve month high of $180.43. The business's 50 day moving average is $162.10 and its two-hundred day moving average is $165.25. The company has a quick ratio of 0.50, a current ratio of 0.71 and a debt-to-equity ratio of 0.47. The stock has a market cap of $376.82 billion, a price-to-earnings ratio of 25.51, a price-to-earnings-growth ratio of 4.58 and a beta of 0.40.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $1.54 EPS for the quarter, beating the consensus estimate of $1.53 by $0.01. Procter & Gamble had a return on equity of 32.67% and a net margin of 18.46%. The company had revenue of $19.78 billion for the quarter, compared to the consensus estimate of $20.42 billion. During the same quarter in the prior year, the business earned $1.52 earnings per share. The firm's revenue for the quarter was down 2.1% on a year-over-year basis. Analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Monday, April 21st were given a $1.0568 dividend. This is an increase from Procter & Gamble's previous quarterly dividend of $1.01. The ex-dividend date was Monday, April 21st. This represents a $4.23 annualized dividend and a dividend yield of 2.63%. Procter & Gamble's dividend payout ratio is presently 67.14%.

Analyst Ratings Changes

PG has been the topic of a number of recent research reports. Redburn Partners set a $161.00 target price on Procter & Gamble in a research report on Thursday, May 1st. Morgan Stanley set a $180.00 target price on Procter & Gamble and gave the company an "overweight" rating in a research report on Friday, April 25th. Barclays reaffirmed an "equal weight" rating on shares of Procter & Gamble in a research report on Thursday, March 27th. Raymond James Financial lowered their target price on Procter & Gamble from $190.00 to $185.00 and set an "outperform" rating on the stock in a research report on Friday, April 25th. Finally, Truist Financial lowered their target price on Procter & Gamble from $185.00 to $180.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Eight investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of "Moderate Buy" and an average target price of $178.45.

Check Out Our Latest Report on PG

Insider Activity at Procter & Gamble

In related news, CEO Jennifer L. Davis sold 1,000 shares of the business's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the completion of the sale, the chief executive officer directly owned 51,965 shares in the company, valued at approximately $8,386,111.70. The trade was a 1.89% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the business's stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $158.67, for a total value of $1,669,208.40. Following the completion of the sale, the insider owned 25,182 shares of the company's stock, valued at approximately $3,995,627.94. This trade represents a 29.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.18% of the company's stock.

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Made in America Stocks Under $20 You Need to See!
3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines